Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response.
Aug 2009 - Cancer Immunol. Immunother.; 58(10):1432-0851 [PMID:19225777]
[Delluc S] [Hachem P] [Rusakiewicz S] [Gaston A] [Marchiol-Fournigault C] [Tourneur L] [Babchia N] [Fradelizi D] [Regnault A] [Sang KH] [Chiocchia G] [Buzyn A]

Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer.
Jul 2009 - Int. J. Oncol.; 35(3):1019-6439 [PMID:19639177]
[Lemoine FM] [Cherai M] [Giverne C] [Dimitri D] [Rosenzwajg M] [Trebeden-Negre H] [Chaput N] [Barrou B] [Thioun N] [Gattegnio B] [Selles F] [Six A] [Azar N] [Lotz JP] [Buzyn A] [Sibony M] [Delcourt A] [Boyer O] [Herson S] [Klatzmann D] [Lacave R]